Immunic (IMUX) Cash from Financing Activities (2013 - 2026)
Immunic (IMUX) posted Cash from Financing Activities of $118,000 for Q2 2026, down 99.8% from $65.52 million a year earlier and down 99.9% from the prior quarter.
Powered by 
Analysis
Immunic (IMUX) Cash from Financing Activities (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Immunic was $188.82 million, up 187.9% year-over-year; for FY2025, it came in at $65.58 million, down 12.0% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of -14.6% (FY2020 to FY2025).
- In prior years, Immunic's Cash from Financing Activities was $74.54 million in FY2024, $1.03 million in FY2023 (-98.9%), $95.76 million in FY2022 (+123.5%) and $42.84 million in FY2021 (-70.3%).
- Quarterly Cash from Financing Activities has run from a low of $51,000 in Q1 2023 to a high of $188.64 million in Q1 2026 over five years.
- The year-over-year decline in Cash from Financing Activities has ranged between 23.4% (Q4 2025) and 99.8% (Q1 2023) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Immunic | 341.81 Mn | -50.53 Mn | - | 118,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118,000.00 |
| Mar 31, 2026 | 188.64 Mn |
| Dec 31, 2025 | 59,000.00 |
| Jun 30, 2025 | 65.52 Mn |
| Dec 31, 2024 | 77,000.00 |
| Mar 31, 2024 | 74.46 Mn |
| Dec 31, 2023 | 604,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 56.04 Mn |
| Jun 30, 2022 | 10.08 Mn |
| Mar 31, 2022 | 29.64 Mn |
| Dec 31, 2021 | 821,000.00 |
| Sep 30, 2021 | 42.02 Mn |
| Dec 31, 2020 | 8.11 Mn |
| Sep 30, 2020 | 96.54 Mn |
| Jun 30, 2020 | 39.21 Mn |
| Mar 31, 2020 | 568,000.00 |
| Dec 31, 2019 | 4.71 Mn |
API Access
Immunic Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMUX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IMUX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMUX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();